We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Columbia China to Build New Hospital in Jiaxing

By HospiMedica International staff writers
Posted on 12 Sep 2017
Print article
Image: An artist’s rendition of the new Columbia Jiaxing Hospital (Photo courtesy of Columbia China).
Image: An artist’s rendition of the new Columbia Jiaxing Hospital (Photo courtesy of Columbia China).
Columbia China (Shanghai, China) has begun construction of a Columbia Jiaxing Hospital in Zhejiang province. The multi-specialty hospital is part of a joint venture between Columbia Pacific Management (Seattle, WA, USA), and investment company Temasek (Singapore).

The hospital, which is expected to open in 2019, is located in the Jiaxing Economic and Technological Development Zone. Once completed, it will have a construction floor area of 120,000m2 with 500 beds; 10 operating theatres; six labor, delivery, recovery and postpartum (LDRP) rooms; and advanced diagnostic equipment. The hospital, which is being constructed at a cost of USD150 million, will serve a population of 4.5 million people who demand quality healthcare services. Patients will be able to use their public and commercial medical insurance.

“Columbia China broke ground on the new hospital today just eight months after acquiring the land; the speed is unprecedented and unheard of in China for a foreign hospital investment,” said Bee Lan Tan, President and CEO of Columbia China. “This would not have been possible without the commitment and efficiency of the Jiaxing government. Columbia China remains dedicated to bringing more international talent and resources to Jiaxing, so that the needs of the local population can be well served.”

“Columbia China strives to deliver the highest level of healthcare quality and service by putting patients at the center of everything we do,” said Nate McLemore, managing director of Columbia Pacific Management. “We are excited to open a hospital in Jiaxing, and are extremely committed to delivering world-class care across China with Columbia China hospitals and Cascade (Kaijian) senior living.”

Columbia Pacific Management has been operating in Asia for 20 years, opening its first hospital in Malaysia in 1996; the network now includes 27 hospitals and two clinics. In 2011 the firm became the first foreign-owned company to receive permission from the Chinese government to build senior care facilities and operates three such facilities, one in Beijing and two in Shanghai. Columbia Pacific also owns a 220-bed orthopedic hospital and two multi-specialty clinics in Shanghai, and is developing two other hospitals in Wuxi and Changzhou.

Related Links:
Columbia China
Columbia Pacific Management
Temasek
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Endocavity Needle Guide
Vitro PRO
New
ECG Air Suction Unit
ECG Air / BT

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.